| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-01-23 | BlackRock Inc. | Fulgent Genetics, Inc. | 3,761,878 | 12.7% | EDGAR |
| SC 13G/A | 2023-01-26 | BlackRock Inc. | Fulgent Genetics, Inc. | 3,527,782 | 12.0% | EDGAR |
| SC 13G | 2023-01-20 | BlackRock Inc. | Fulgent Genetics, Inc. | 3,527,782 | 12.0% | EDGAR |
| SC 13D/A | 2022-11-10 | Hsieh Ming | Fulgent Genetics, Inc. | 8,684,102 | 29.5% | EDGAR |
| SC 13G/A | 2022-01-27 | BlackRock Inc. | Fulgent Genetics, Inc. | 3,421,251 | 11.5% | EDGAR |
| SC 13G/A | 2022-01-26 | BlackRock Inc. | Fulgent Genetics, Inc. | 3,421,251 | 11.5% | EDGAR |
| SC 13G/A | 2021-07-12 | BlackRock Inc. | Fulgent Genetics, Inc. | 3,057,315 | 10.5% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | Fulgent Genetics, Inc. | 1,984,867 | 8.2% | EDGAR |
| SC 13D | 2020-12-22 | Ming Hsieh Trust | Fulgent Genetics, Inc. | 7,897,115 | 32.5% | EDGAR |
| SC 13D/A | 2020-09-17 | Gao Hanlin | Fulgent Genetics, Inc. | 803,379 | 3.6% | EDGAR |
| SC 13G/A | 2020-06-12 | Xi Long USA, Inc. | Fulgent Genetics, Inc. | 1,068,156 | 4.9% | EDGAR |
| SC 13G/A | 2020-06-02 | Xi Long USA, Inc. | Fulgent Genetics, Inc. | 1,175,441 | 5.4% | EDGAR |
| SC 13D/A | 2019-10-24 | Hsieh Ming | Fulgent Genetics, Inc. | 7,897,115 | 42.7% | EDGAR |
| SC 13D/A | 2019-09-13 | Gao Hanlin | Fulgent Genetics, Inc. | 1,767,659 | 9.6% | EDGAR |
| SC 13D | 2016-10-11 | Gao Hanlin | Fulgent Genetics, Inc. | 1,767,659 | 10.0% | EDGAR |
| SC 13D | 2016-10-11 | Hsieh Ming | Fulgent Genetics, Inc. | 7,760,733 | 43.9% | EDGAR |
| SC 13G | 2016-10-11 | Xi Long USA, Inc. | Fulgent Genetics, Inc. | 2,025,623 | 11.5% | EDGAR |